In case you missed this Tumori Journal post, here dr Andrei_Fodor presents their article 👇👇👇 x.com/DrAndreiFodor/…

I am proud to announce that The Green Journal Radiotherapy & Oncology now has an Impact Factor of 5.3 🎉 This achievement reflects the strength, relevance, and impact of the research we publish in the field of radiation oncology. Submit your best research: thegreenjournal.com

Proud to share our ESTRO manifesto published in Radiotherapy & Oncology A call to reposition radiation oncology at the heart of integrated cancer care Open access for 50 days authors.elsevier.com/a/1lRcWcA0-MUMK #RadOnc #ESTRO #OncoAlert OncoAlert sciencedirect.com/science/articl…

Arches National Park [📸 Elliot McGucken]

💥 Proud to belong to the 🔝 Medical Schools in 🇮🇹 👉🏻 in smaller schools students receive 1-1 attention from advisors and faculty, which may result in a better education #universitychallenge Università degli Studi di Milano-Bicocca

Adjuvant cemiplimab led to to longer disease-free survival than placebo in cutaneous squamous-cell carcinoma with a high risk for recurrence fondazionebonadonna.org/en/cemiplimab-… #FondazioneBonadonna #Oncology #CancerResearch Giampaolo Bianchini Carmen Criscitiello Maurizio Callari

Top #BreastCancer Oncologists for July 2025, curated by LARVOL CLIN. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights | Paolo Tarantino | Yakup Ergün

So proud to share mid-term results of our POPART trial on prostate bed SBRT — core of my thesis and a project I deeply believe in ✨ Alongside #SCIMITAR & #SHORTER, another step towards the 5fx revolution! 💥 Forever🙏🏼Stefano Arcangeli 50days free access⬇️ authors.elsevier.com/c/1lYbQcA0-MUS1

Goya ha detto che il sonno della ragione genera mostri. Quando però si arriva alle questioni che riguardano la salute, il sonno della ragione genera i morti. Oggi un mio commento su Repubblica repubblica.it/cronaca/2025/0…

Are patients with cardiac calcifications the ones who really need attention when planning breast irradiation? Read our department’s study published in Radiotherapy & Oncology for an initial answer! kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

Ho letto il post di #Borghi. Riassumo e chiarisco i punti chiave (spoiler, fa l'ennesima figuraccia) Cosa dice Borghi Accusa i medici e in particolare virologi o divulgatori come #Burioni e #Cartabellotta di non capire nulla di analisi statistica. Cosa c'è di vero?

Io ho giurato di non rispondergli mai più e devo mantenere il giuramento anche perché ho scommesso un sacco di soldi. Però è molto difficile resistere quando un sedicente economista mette in discussione l’efficacia di un vaccino in uso da 63 (sessantatré) anni in tutto il mondo.

CHAARTED Ten-year survival rates: Time to re-think de-escalation! Achieving a PSA nadir below 0.2 ng/mL within 6 months is a strong predictor of overall survival, supporting its role in response-adapted de-escalation strategies. Annals of Oncology ESMO - Eur. Oncology ECOG-ACRIN Cancer Research Group Elizabeth Plimack MD

Who benefits most from chemoradiotherapy? PORTEC-3 delivers the decade-long answer 🔍 Adjuvant CRT vs RT in high-risk endometrial cancer 🦾 Arms • RT alone (48.6 Gy pelvic RT) • CRT = RT + Cisplatin → Carboplatin-Paclitaxel 📊 10-year Results • OS: 74.4% vs 67.3% → HR

Non possiamo rincorrere le malattie trasmesse da zanzare: dobbiamo prevenirle.

Nearly 30 years, 100 H Index —career path in oncology comes with sacrifices, setbacks, and the strength to rise again. My journey began at Columbia in the ‘90s, studying bladder cancer and DNA adducts. Keep pushing through the challenges! ESMO - Eur. Oncology Università degli Studi di Milano IEO

Quelli di Dissapore barano giocando con le parole e mettono in pericolo la salute delle persone più vulnerabili. Non può essere concesso.

Short-term cardioprotection with bisoprolol/ramipril significantly reduces right ventricular dysfunction in #breastcancer patients receiving #anthracyclines (SAFE trial substudy) 🫀 RV CTRCD at 24 months: 📉 49.2% placebo vs 22% European Society of Cardiology OncoAlert onlinelibrary.wiley.com/doi/10.1111/ec…

La ricerca più avanzata dà nuova vita a vecchi farmaci. L'aspirina dimezza la recidiva di alcuni tipi di cancro al colon-retto. Alla faccia di Big Pharma. burioni.substack.com